DLGAP2-AS1

Across TCGA pan-cancer cohorts, DLGAP2-AS1 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of DLGAP2-AS1’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where DLGAP2-AS1 RNA is repressed in tumor relative to normal tissue. In most cancer types DLGAP2-AS1 is over-expressed in tumor, although a few such as KIRP and KIRC show the opposite, repressed pattern.

KIRP, KIRC, and UCEC are the cancer types where DLGAP2-AS1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in DLGAP2-AS1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRP	All	All	−0.083	<.001	7	view →
KIRC	Male	All	−0.052	<.001	4	view →
UCEC	All	All	−0.023	.044	2	view →
LUSC	Male	All	−0.010	.023	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

DLGAP2-AS1–KIRP

Open the KIRP breakdown →